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Breast cancer is the most common cancer in females.[1] Invasive 
micropapillary carcinoma (IMPC) of the breast is a clinically 
aggressive and rare form of invasive ductal carcinoma (IDC), 
accounting for <6% of breast cancer cases.[2,3] There are no specific 
distinguishing features to differentiate between IMPC and IDC, and 
80% of patients have lymph node metastasis at presentation with 
histological findings highly positive for oestrogen receptor (ER) 
and human epidermal growth receptor-2 (c-erbB-2) (88% and 84%, 
respectively).[4-6] IMPC was first described in 1980, and it was thought 
that patients with IMPC experience worse outcomes than those with 
IDC because of its higher propensity for lymph-vascular invasion and 
lymph node metastasis.[4-8] The main objective of this case report is to 
share our experience with IMPC and give a literature review of the 
standard of care. Ethical approval was obtained from the Pietersburg/
Mankweng Hospital Research Ethics Committee (ref no. PMREC 
25 AUGUST UL 2021/E).
Case presentation
An 81-year-old African female patient presented at Mankweng 
Hospital breast oncology clinic (Limpopo Province, South Africa) 
as a referral from a peripheral hospital. The main complaint was 
progressive swelling of the left upper limb involving the ipsilateral 
breast. According to the patient, she had a prick on the left hand 
for more than 18 months, then her upper limb was progressively 
swelling and ultimately led to left breast involvement. She consulted 
various traditional healers at the time when she started experiencing 
symptoms; however, there was no improvement to her condition. It is 
at this point that she started seeking medical attention at her local 
hospital more than a year after the onset of her symptoms. A biopsy 
on the breast mass was done on the initial presentation prior to breast 
oncology referral.
She was a healthy individual, multiparous with a total of 5 children. 
The onset of menarche and menopause is not known, and she had no 
significant family history of breast cancer.
Upon examination, the left upper limb was swollen from the fingers 
all the way through to the shoulder joint and also involving the left 
breast. There were multiple ulcerated lesions and masses of various 
sizes on the breast, axilla and shoulder region (Fig.  1). There was 
notable peau d’orange skin changes and nipple retraction. There were 
no obvious abnormalities detected on the contralateral upper limb, 
and cardiovascular, respiratory, abdomen and musculoskeletal systems.
Histopathological evaluation of the incision biopsy of the left 
breast mass showed skin-surfaced tissue, invasive neoplasm, and 
small nests of malignant cells, largely involving the lymphatic vessels. 
There were markedly pleomorphic cells that displayed brisk mitotic 
activity and showed no tubule-forming behaviour. No evidence of 
ductal carcinoma in situ was displayed in the tissue section. These 
features are in keeping with IMPC.
The patient was referred to the medical oncology clinic; however, 
she ultimately succumbed to her illness before the date of her 
treatment.
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Invasive micropapillary carcinoma (IMPC) of the breast is a clinically aggressive rare form of breast cancer. Patients with IMPC present with 
higher clinical stages, higher histological degrees, higher rate of lymph-vascular invasion and axillary lymph node extracapsular extension. 
In this case report, we seek to explore and share our experience of invasive micropapillary carcinoma of the breast and give a literature 
review of the standard of care.
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Fig. 1. Advanced left-sided breast cancer with ulcerated lesions, masses of 
various sizes and also extending to the left upper limb.
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Discussion
The most common presentation of IMPC is a breast lump (61%) that 
may be associated with nipple retraction and/or erythema. The left 
breast has been shown to be commonly involved (71% of the IMPC 
cases), followed by the right breast (25%) and both breasts in 3% of 
the cases.[2]
Imaging studies show features of a typical breast malignancy, 
with MRI further showing features of lymphatic infiltration.[2,5] This 
implies that MRI can be used for diagnosis and treatment planning.[5]
Patients with IMPC present with higher clinical stages, higher 
histological degrees, higher rate of lymph-vascular invasion and 
axillary lymph node extracapsular extension.[7,8] IMPC patients 
have been shown to have a more unfavourable prognosis for 
loco-regional recurrence than IDC patients. However, there is no 
statistically significant difference between patients with IMPC and 
IDC as indicated by relapse-free survival (odds ratio (OR) 2.04; 95% 
confidence interval (CI) 1.63 - 2.55) and local regional recurrence-
free survival (OR 2.82; 95% CI 1.90 - 4.17),[6,7,9-12] suggesting that 
radical or proactive clinical therapy is unnecessary. Treatment 
is individualised to include tailored therapeutic interventions or 
multidisciplinary approaches.
Conclusion
Invasive micropapillary carcinoma is a rare aggressive variant of 
breast cancer. Its frequent lymph-vascular invasion and high tumour 
grades correlate with its aggressive nature; however, no significant 
difference in overall survival has been proven yet. Patients must be 
encouraged to seek medical attention early as this can aid in better 
prognosis, and reduced morbidity and mortality. 
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